TY  - JOUR
AU  - Alonso, Rafael
AU  - Cedena, María Teresa
AU  - García, Cristina
AU  - Valeri, Antonio
AU  - Sánchez, Ricardo
AU  - Collado Yurrita, Luis Rodolfo
AU  - Lahuerta Palacios, Juan José
AU  - Martínez López, Joaquín
PY  - 2020
DO  - 10.1182/bloodadvances.2020001508
SN  - 2473-9537
UR  - https://hdl.handle.net/20.500.14352/128258
T2  - Blood advances
AB  - Lenalidomide is an immunomodulatory drug approved for maintenance treatment in newly diagnosed multiple myeloma, and it has been shown to improve progression-free survival (PFS) and, in several studies, overall survival. Nevertheless, the impact of...
LA  - eng
M2  - 2163
PB  - The American Society of Hematology
TI  - Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma
TY  - journal article
VL  - 4
ER  -